IN2013MU00646A - - Google Patents

Download PDF

Info

Publication number
IN2013MU00646A
IN2013MU00646A IN646MU2013A IN2013MU00646A IN 2013MU00646 A IN2013MU00646 A IN 2013MU00646A IN 646MU2013 A IN646MU2013 A IN 646MU2013A IN 2013MU00646 A IN2013MU00646 A IN 2013MU00646A
Authority
IN
India
Prior art keywords
preparation
present
crystalline form
provides novel
endoxifen
Prior art date
Application number
Other languages
English (en)
Inventor
Jagdish Desai Sanjay
Dinkarrai Desai Brijesh
Viththal Guna Jayesh
Chandulal Patel Sunil
Original Assignee
Intas Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intas Pharmaceuticals Ltd filed Critical Intas Pharmaceuticals Ltd
Priority to IN646MU2013 priority Critical patent/IN2013MU00646A/en
Priority to PCT/IN2014/000136 priority patent/WO2014141292A2/en
Publication of IN2013MU00646A publication Critical patent/IN2013MU00646A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN646MU2013 2013-03-04 2014-03-03 IN2013MU00646A (en))

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN646MU2013 IN2013MU00646A (en)) 2013-03-04 2014-03-03
PCT/IN2014/000136 WO2014141292A2 (en) 2013-03-04 2014-03-03 Endoxifen citrate polymorph and process for preparing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN646MU2013 IN2013MU00646A (en)) 2013-03-04 2014-03-03

Publications (1)

Publication Number Publication Date
IN2013MU00646A true IN2013MU00646A (en)) 2015-06-26

Family

ID=51538243

Family Applications (1)

Application Number Title Priority Date Filing Date
IN646MU2013 IN2013MU00646A (en)) 2013-03-04 2014-03-03

Country Status (2)

Country Link
IN (1) IN2013MU00646A (en))
WO (1) WO2014141292A2 (en))

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180012853A (ko) 2015-06-16 2018-02-06 지앙수 헨그루이 메디슨 컴퍼니 리미티드 피페리딘 유도체 및 이의 제조 방법 및 약학적 용도
BR112018011817A2 (pt) 2015-12-22 2018-12-04 Jiangsu Hengrui Medicine Co derivado de benzopiperidina, método de preparação do mesmo, e uso médico do mesmo
US11261151B2 (en) 2017-09-11 2022-03-01 Atossa Therapeutics, Inc. Methods for making and using endoxifen
ES2912740T3 (es) 2017-11-14 2022-05-27 Kind Pharmaceutical Compuesto heterocíclico y aplicación del mismo en medicina
US12201591B2 (en) 2019-07-03 2025-01-21 Atossa Therapeutics, Inc. Sustained release compositions of endoxifen
EP4089094A4 (en) 2020-01-10 2023-08-02 Jiangsu Hengrui Pharmaceuticals Co., Ltd. TRICYCLIC TETRAHYDROISOQUINOLINE DERIVATIVE, METHOD FOR PREPARING IT AND ITS APPLICATION IN MEDICINE
US20210315844A1 (en) * 2020-04-10 2021-10-14 Jina Pharmaceuticals, Inc. Endoxifen for the treatment of bipolar i disorder
AU2021252229A1 (en) 2020-04-10 2022-10-27 Jina Pharmaceuticals, Inc. Endoxifen for the treatment of bipolar I disorder
EP4132498A4 (en) 2020-04-10 2024-04-17 Jina Pharmaceuticals Inc. Endoxifen for the treatment of bipolar i disorder
CA3225268A1 (en) 2021-07-09 2023-01-12 Lina Jia Salt types of tricyclic tetrahydro isoquinoline derivative
EP4463437A2 (en) 2022-01-12 2024-11-20 Atossa Therapeutics, Inc. Compositions of (z)-endoxifen and methods of enrichment thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW593256B (en) * 1999-11-16 2004-06-21 Hormos Medical Oy Ltd Triphenylalkene derivatives and their use as selective estrogen receptor modulators
US20090291134A1 (en) * 2006-11-21 2009-11-26 Jina Pharmaceuticals, Inc. Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases
WO2009120999A2 (en) * 2008-03-28 2009-10-01 Olema Pharmaceuticals, Inc. Use of an endoxifen prodrug for treatment of breast cancer
KR101308258B1 (ko) * 2010-10-15 2013-09-13 씨제이제일제당 (주) 엔독시펜의 신규한 제조 방법

Also Published As

Publication number Publication date
WO2014141292A2 (en) 2014-09-18
WO2014141292A3 (en) 2014-12-24

Similar Documents

Publication Publication Date Title
IN2013MU00646A (en))
IN2014CH00247A (en))
MX370649B (es) Proceso para la preparacion de teneligliptina.
IN2013MU00848A (en))
IL249872A0 (en) Amorphous form of eliglostat hemetrate, preparations containing it and methods for its preparation
IN2014MU00455A (en))
IL245474A0 (en) Process for the preparation of 5-fluoro-1h-pyrazoles
IL245476A0 (en) Process for preparing 5-fluoro-1h-pyrazoles
IN2013MU03070A (en))
MA40447A (fr) Composition pharmaceutique orale d'isotrétinoïne
MA40312A (fr) Composition pharmaceutique orale d'isotrétinoïne
IN2013MU01113A (en))
PL2967095T3 (pl) Sposób wytwarzania serów o zmienionej strukturze
EP3016935A4 (en) Process for the preparation of intermediate of dolutegravir
PL2964607T3 (pl) Sposób wytwarzania halogeno-n,n-dimetylobenzyloamin
IL229326A (en) Process for making n-iodine-affluent
WO2014170909A3 (en) Process for pomalidomide
IN2013MU02528A (en))
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
MX382969B (es) Método para producir halocetonas.
IN2014CH01391A (en))
IN2013MU03768A (en))
IN2013MU01501A (en))
IN2013MU01524A (en))
IN2013CH05395A (en))